Roche Holding AG

2024. aug. 7. 07:03 UTC

Roche Weighs Divestment of Cancer Data Startup, FT Reports

2024. aug. 5. 22:43 UTC

Poseida Rises After Reporting Smaller-Than-Seen Loss, Partnership Progress

2024. júl. 25. 07:14 UTC

Roche Raises Earnings Guidance After Results Beat Market Expectations -- Update

2024. júl. 25. 05:49 UTC

Roche Raises Guidance After Sales, Earnings Beat Market Expectations

2024. jún. 20. 23:05 UTC

Sarepta Shares Soar 37% Following Expanded Approval for Elevidys

2024. aug. 19. 20:01 UTC

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter -- IBD

2024. aug. 7. 14:22 UTC

It Isn't Time to Worry About Wegovy Yet -- Heard on the Street -- WSJ

2024. júl. 29. 05:04 UTC

Roche: Deal Was Announced at the End of 2023

2024. júl. 29. 05:03 UTC

Roche: To Move on the Full Integration of the Acquisition

2024. júl. 29. 05:02 UTC

Roche: Acquisition Received All Required Antitrust and Regulatory Clearances

2024. júl. 29. 05:01 UTC

Roche Closes Acquisition of LumiraDx's Point of Care Technology

2024. júl. 25. 13:20 UTC

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

2024. júl. 25. 07:35 UTC

Roche Surprises With Guidance Lift -- Market Talk

2024. júl. 25. 05:10 UTC

Roche 1H Oper Pft CHF9.07B

2024. júl. 25. 05:10 UTC

Roche 1H Net Pft CHF6.26B

2024. júl. 25. 05:08 UTC

Roche Had Seen Core Earnings Per Share Grow Mid-Single-Digit At Constant Currency When Excluding Impact From Tax Disputes in 2023

2024. júl. 25. 05:06 UTC

Roche Expects To Further Increase Its Dividend in 2024

2024. júl. 25. 05:06 UTC

Roche Sees 2024 Core Earnings Per Share To Grow High Single Digit At Constant Currency When Excluding Impact From Tax Disputes in 2023

2024. júl. 25. 05:04 UTC

Roche Expects an Increase in Group Sales in the Mid Single Digit Range at Constant Currency

2024. júl. 25. 05:03 UTC

Roche Raises 2024 View

2024. júl. 25. 05:03 UTC

Roche 1H Diagnostics Sales Rose 5% at Constant Currency

2024. júl. 25. 05:02 UTC

Roche 1H Pharmaceutical Sales Rose 5% at Constant Currency

2024. júl. 25. 05:02 UTC

Roche 1H Sales Grew 5% at Constant Currency

2024. júl. 25. 05:02 UTC

Analysts Saw Roche 1H Core EPS at CHF9.24

2024. júl. 25. 05:02 UTC

Roche 1H Adj EPS CHF10.23

2024. júl. 25. 05:01 UTC

Analysts Saw Roche 1H Sales at CHF29.38B

2024. júl. 25. 05:01 UTC

Roche 1H Sales CHF29.85B

2024. júl. 5. 08:16 UTC

Roche's FDA Approval for Eye Drug Won't Be a Game Changer -- Market Talk

2024. júl. 4. 08:29 UTC

Roche's Halted Lung Cancer Trial Doesn't Come as a Surprise -- Market Talk

2024. jún. 17. 09:13 UTC

Roche Defends Blood Disorder Drug as Competition from Novo Nordisk Looms -- Market Talk